デジタルPCR市場レポート：製品タイプ、技術、用途、地域別、2024～2032年

世界のデジタルPCR市場規模は2023年に47億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに107億米ドルに達し、2024～2032年の間に9.25%の成長率（CAGR）を示すと予測しています。核酸定性の精度向上、リキッドバイオプシー需要の高まり、ゲノム研究の著しい進歩、バイオテクノロジーと製薬産業の拡大、広範な研究投資活動は、市場を推進する主要要因の一部です。

デジタルPCR（デジタルポリメラーゼ連鎖反応）は、様々な用途でDNAやRNAなどの核酸を定量・分析するために使用される高精度で高度な分子生物学技術です。単一のエンドポイント測定しか提供しない従来のPCRとは異なり、デジタルPCRはサンプルを物理的またはデジタル的に何千もの小さな個々の反応に分割します。これは標的核酸の絶対定量を可能にし、比類のない感度と精度を記載しています。デジタルPCRはゲノミクス、臨床診断、環境モニタリングなどのセグメントで役立っています。まれな突然変異の検出、遺伝子発現の定量化、ウイルス負荷の評価などの能力により、遺伝性疾患の理解、治療反応のモニタリング、微生物群集の研究において貴重なツールとなっています。その定量的な性質と阻害剤に対する最小限の感受性により、重要なアプリケーションにおいて高い信頼性があります。

デジタルPCRは核酸定量において優れた精度と感度を提供し、ゲノミクス、診断、製薬研究において不可欠なツールとなっています。さらに、がんの検出とモニタリングのためのリキッドバイオプシーが人気を集めています。血液やその他の体液中のまれな変異やコピー数の変動を検出するdPCRの能力は、この重要なセグメントでの採用を後押ししています。この他にも、dPCRは感染症や遺伝性疾患の診断、ウイルス量のモニタリングにおいて極めて重要な役割を果たしています。これは、COVID-19のパンデミックのような世界の健康問題において特に重要です。このほか、バイオテクノロジーや製薬のセグメントでは、研究開発のための堅牢なツールが絶えず求められています。dPCRは、医薬品開発やバイオ製造プロセスにおける正確な定量を可能にすることで、このニーズに応えています。これと同様に、水や土壌中の病原体の検出を含む環境モニタリングは、低レベルの汚染物質の検出における精度と信頼性から、dPCRに依存しています。dPCRは精密な遺伝子解析を容易にし、画期的な発見に貢献します。

デジタルPCR市場の動向と促進要因：

核酸定量における精度の向上

デジタルPCRは核酸定量において比類のないレベルの精度を記載しています。相対測定に頼る従来の定量PCR（qPCR）とは異なり、dPCRは絶対定量を記載しています。この精度は、サンプルを何千もの別々の反応に分割し、存在する標的分子の数を効果的にカウントすることによって達成されます。このレベルの精度は、がんにおける稀な遺伝子変異の検出、診断試験の信頼性の確保、感染症におけるウイルス量の変化の追跡など、様々なアプリケーションにおいて不可欠です。

リキッドバイオプシー需要の高まり

血液やその他の体液を分析してがん関連のバイオマーカーを調べるリキッドバイオプシーは、がんの早期発見や治療モニタリングにおいてますます重要になってきています。デジタルPCRの感度は微量の変異DNAまたはRNAの検出を可能にし、リキッドバイオプシーアッセイにおいて極めて重要な技術となっています。臨床医はdPCRを用いて様々ながんに関連する特定の遺伝子変異を同定し、個別化治療戦略のための貴重な情報を提供することができます。

ゲノム研究の著しい進歩

ゲノミクスのセグメントは、疾患の遺伝的基盤を理解し、標的療法を開発する必要性によって、進化し続けています。デジタルPCRは、科学者が遺伝子発現を正確に定量化し、稀な遺伝子変異を検出し、コピー数の変異を研究することを可能にすることによって、この研究において中心的な役割を果たしています。これらの能力は、疾患の原因となる遺伝的要因を明らかにし、潜在的な創薬標的を同定し、治療介入を最適化するために不可欠です。ゲノム研究が拡大するにつれて、遺伝子解析の精度と再現性の両方を提供するツールとしてのdPCRの需要も高まっています。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査目的
• 利害関係者
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要産業動向

第5章 デジタルPCRの世界市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：製品タイプ別

• デジタルPCR装置
• 消耗品・試薬
• ソフトウェアとサービス

第7章 市場内訳：技術別

• 液滴デジタルPCR
• ビーミングデジタルPCR

第8章 市場内訳：用途別

• 臨床診断
• フォレンジック
• 研究
• その他

第9章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Avance Biosciences Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • JN Medsys
  • OPTOLANE Technologies Inc.
  • QIAGEN
  • SAGA Diagnostics AB
  • Standard BioTools Inc.
  • Stilla Technologies
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

List of Figures

• Figure 1: Global: Digital PCR Market: Major Drivers and Challenges
• Figure 2: Global: Digital PCR Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Digital PCR Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 4: Global: Digital PCR Market: Breakup by Product Type (in %), 2023
• Figure 5: Global: Digital PCR Market: Breakup by Technology (in %), 2023
• Figure 6: Global: Digital PCR Market: Breakup by Application (in %), 2023
• Figure 7: Global: Digital PCR Market: Breakup by Region (in %), 2023
• Figure 8: Global: Digital PCR (Digital PCR Equipment) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 9: Global: Digital PCR (Digital PCR Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 10: Global: Digital PCR (Consumables and Reagents) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 11: Global: Digital PCR (Consumables and Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 12: Global: Digital PCR (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 13: Global: Digital PCR (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 14: Global: Digital PCR (Droplet Digital PCR) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 15: Global: Digital PCR (Droplet Digital PCR) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 16: Global: Digital PCR (BEAMing Digital PCR) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 17: Global: Digital PCR (BEAMing Digital PCR) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 18: Global: Digital PCR (Clinical Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 19: Global: Digital PCR (Clinical Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 20: Global: Digital PCR (Forensics) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 21: Global: Digital PCR (Forensics) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 22: Global: Digital PCR (Research) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 23: Global: Digital PCR (Research) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 24: Global: Digital PCR (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 25: Global: Digital PCR (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 26: North America: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 27: North America: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 28: United States: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 29: United States: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 30: Canada: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 31: Canada: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 32: Asia-Pacific: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 33: Asia-Pacific: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 34: China: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 35: China: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 36: Japan: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 37: Japan: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 38: India: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 39: India: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 40: South Korea: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 41: South Korea: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 42: Australia: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 43: Australia: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 44: Indonesia: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 45: Indonesia: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 46: Others: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 47: Others: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 48: Europe: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 49: Europe: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 50: Germany: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 51: Germany: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 52: France: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 53: France: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 54: United Kingdom: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 55: United Kingdom: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 56: Italy: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 57: Italy: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 58: Spain: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 59: Spain: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 60: Russia: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 61: Russia: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 62: Others: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 63: Others: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 64: Latin America: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 65: Latin America: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 66: Brazil: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 67: Brazil: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 68: Mexico: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 69: Mexico: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 70: Others: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 71: Others: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 72: Middle East and Africa: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
• Figure 73: Middle East and Africa: Digital PCR Market: Breakup by Country (in %), 2023
• Figure 74: Middle East and Africa: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 75: Global: Digital PCR Industry: SWOT Analysis
• Figure 76: Global: Digital PCR Industry: Value Chain Analysis
• Figure 77: Global: Digital PCR Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Digital PCR Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Digital PCR Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
• Table 3: Global: Digital PCR Market Forecast: Breakup by Technology (in Million US$), 2024-2032
• Table 4: Global: Digital PCR Market Forecast: Breakup by Application (in Million US$), 2024-2032
• Table 5: Global: Digital PCR Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 6: Global: Digital PCR Market: Competitive Structure
• Table 7: Global: Digital PCR Market: Key Players

The global digital PCR market size reached US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.7 Billion by 2032, exhibiting a growth rate (CAGR) of 9.25% during 2024-2032. The increased precision in nucleic acid qualification, rising demand for liquid biopsies, significant advancements in genomic research, expanding biotechnology and pharmaceutical industries, and extensive research and investment activities are some of the major factors propelling the market.

Digital PCR, or digital polymerase chain reaction, is a highly precise and advanced molecular biology technique used for quantifying and analyzing nucleic acids, such as DNA and RNA, in various applications. Unlike traditional PCR, which provides only a single endpoint measurement, digital PCR partitions the sample into thousands of tiny individual reactions, either physically or digitally. This allows for the absolute quantification of the target nucleic acid, offering unparalleled sensitivity and accuracy. Digital PCR is instrumental in fields like genomics, clinical diagnostics, and environmental monitoring. Its ability to detect rare mutations, quantify gene expression, and assess viral loads has made it a valuable tool in understanding genetic diseases, monitoring treatment responses, and studying microbial communities. Its quantitative nature and minimal susceptibility to inhibitors make it highly reliable in critical applications.

Digital PCR offers superior accuracy and sensitivity in nucleic acid quantification, making it an indispensable tool in genomics, diagnostics, and pharmaceutical research. Additionally, liquid biopsies for cancer detection and monitoring are gaining traction. The ability of dPCR to detect rare mutations and copy number variations in blood and other bodily fluids fuels its adoption in this critical field. Other than this, dPCR plays a pivotal role in diagnosing infectious diseases, genetic disorders, and monitoring viral loads. This is particularly crucial in the context of global health concerns, such as the COVID-19 pandemic. Besides this, the biotech and pharmaceutical sectors continually demand robust tools for research and development. dPCR meets this need by enabling precise quantification in drug development and biomanufacturing processes. In line with this, environmental monitoring, including the detection of pathogens in water and soil, relies on dPCR for its accuracy and reliability in detecting low-level contaminants. Moreover, genomic research is expanding, driven by the need to understand genetic contributions to diseases and develop personalized medicine. dPCR facilitates precise genetic analysis, aiding in breakthrough discoveries.

Digital PCR Market Trends/Drivers:

Increased Precision in Nucleic Acid Quantification

Digital PCR offers an unparalleled level of precision in quantifying nucleic acids. Unlike traditional quantitative PCR (qPCR), which relies on relative measurements, dPCR provides absolute quantification. This precision is achieved by partitioning the sample into thousands of separate reactions, effectively counting the number of target molecules present. This level of accuracy is essential in various applications, such as detecting rare genetic mutations in cancer, ensuring the reliability of diagnostic tests, and tracking viral load changes in infectious diseases.

Rising Demand for Liquid Biopsies

Liquid biopsies, which involve analyzing blood or other bodily fluids for cancer-related biomarkers, are becoming increasingly important in early cancer detection and treatment monitoring. Digital PCR's sensitivity enables the detection of minute amounts of mutated DNA or RNA, making it a pivotal technology in liquid biopsy assays. Clinicians can use dPCR to identify specific genetic mutations associated with various cancers, providing valuable information for personalized treatment strategies.

Significant Advancements in Genomic Research

The field of genomics continues to evolve, driven by the need to understand the genetic basis of diseases and develop targeted therapies. Digital PCR plays a central role in this research by allowing scientists to precisely quantify gene expression, detect rare genetic variants, and study copy number variations. These capabilities are vital for uncovering genetic factors contributing to diseases, identifying potential drug targets, and optimizing therapeutic interventions. As genomic research expands, so does the demand for dPCR as a tool that offers both accuracy and reproducibility in genetic analysis.

Digital PCR Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global digital PCR market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product type, technology and application.

Breakup by Product Type:

Digital PCR Equipment

Consumables and Reagents

Software and Services

Digital PCR equipment dominates the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes digital PCR equipment, consumables and reagents, and software and service. According to the report, digital PCR equipment represented the largest segment.

The pivotal role of digital PCR equipment in molecular biology and genetic research positions it as a fundamental tool in laboratories worldwide. The demand for precise nucleic acid quantification, which digital PCR equipment excels in, continues to rise across various applications, including genomics, diagnostics, and environmental monitoring. Additionally, as scientific understanding advances and the need for high-throughput and sensitive techniques grows, digital PCR equipment stands out as the preferred choice. Its ability to detect and quantify rare genetic mutations, copy number variations, and low-level viral loads has made it indispensable in fields like cancer research, infectious disease diagnostics, and monitoring of genetic disorders. Furthermore, ongoing technological advancements in digital PCR platforms, automation, and integration with other laboratory systems have made this equipment more user-friendly and efficient, driving its adoption in both research and clinical settings.

Breakup by Technology:

Droplet Digital PCR

BEAMing Digital PCR

Droplet digital PCR holds the largest share in the market

A detailed breakup and analysis of the market based on technology has also been provided in the report. This includes droplet digital PCR and BEAMing digital PCR. According to the report, droplet digital PCR accounted for the largest market share.

Droplet digital PCR (ddPCR), combines the precision of digital PCR (dPCR) with increased throughput, making it an attractive choice for researchers and diagnosticians. This technology partitions a sample into thousands of tiny droplets, each serving as an individual reaction vessel. This parallelization significantly enhances the sensitivity and accuracy of nucleic acid quantification. Additionally, ddPCR excels in applications that require absolute quantification, especially in situations where rare mutations, copy number variations, or low-abundance targets need to be detected. Its ability to provide an absolute count of target molecules within a sample, rather than relying on relative measurements, is a significant advantage in genomics, cancer research, and clinical diagnostics. Other than this, ddPCR offers robustness in the presence of inhibitors, making it suitable for challenging sample types, such as those found in environmental monitoring or clinical specimens. This resilience to inhibitory substances enhances the reliability and versatility of technology.

Breakup by Application:

Clinical Diagnostics

Forensics

Research

Others

Clinical diagnostics dominate the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes clinical diagnostics, forensics, research, and others. According to the report, clinical diagnostics represented the largest segment.

The ever-growing emphasis on healthcare and wellness globally has spurred an increased demand for accurate and timely diagnostic tests. As the population ages and health concerns become more prevalent, the need for early disease detection and monitoring has surged, leading to a substantial uptick in clinical diagnostic services. Furthermore, advancements in technology have played a pivotal role in enhancing the precision and speed of diagnostic procedures, making them more accessible and reliable. In addition, the COVID-19 pandemic brought to the forefront the importance of diagnostic testing, underscoring the critical role of clinical diagnostics in public health.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America has a well-established and highly sophisticated healthcare infrastructure, including a robust network of clinical laboratories and research institutions. This infrastructure fosters the adoption of advanced molecular diagnostic techniques like dPCR, particularly in the United States and Canada, where healthcare expenditure is substantial. Additionally, the region is at the forefront of genomics and personalized medicine research. The demand for precise nucleic acid quantification technologies like dPCR is driven by the region's extensive genomic research initiatives and the increasing emphasis on tailoring medical treatments to individual patients. Other than this, the region has a thriving biotechnology and pharmaceutical industry that relies heavily on dPCR for drug development, clinical trials, and quality control processes. The versatility and accuracy of dPCR technology make it an essential tool in these sectors. Furthermore, North America has been quick to adopt innovative diagnostic technologies, especially in response to public health crises like the COVID-19 pandemic. The use of dPCR for virus detection and monitoring has further propelled its growth in the region.

Competitive Landscape:

Leading companies consistently invest in R&D to develop innovative dPCR platforms with improved sensitivity, automation, and scalability. These advancements cater to the evolving needs of researchers and clinicians across various applications. Additionally, numerous major players have established collaborations with academic institutions, research organizations, and other industry stakeholders. These partnerships facilitate the exchange of knowledge, expertise, and resources, leading to the development of cutting-edge dPCR technologies. Other than this, to address a wide range of applications, key players have expanded their product portfolios to include different dPCR platforms and consumables. This allows them to cater to diverse customer needs and preferences. Besides this, companies have pursued strategies to expand their presence in emerging markets, capitalizing on the increasing adoption of dPCR technologies in regions with growing healthcare and biotechnology sectors. In line with this, key players invest in marketing campaigns to raise awareness about the benefits of dPCR. These efforts target both existing and potential customers, highlighting the advantages of technology in research, diagnostics, and other applications.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Avance Biosciences Inc.

Bio-Rad Laboratories Inc.

Danaher Corporation

JN Medsys

OPTOLANE Technologies Inc.

QIAGEN

SAGA Diagnostics AB

Standard BioTools Inc.

Stilla Technologies

Sysmex Corporation

Thermo Fisher Scientific Inc.

Recent Developments:

Standard Bio Tools Inc. has recently unveiled the X9 Real-Time PCR System, a cutting-edge genomics instrument designed to deliver exceptional efficiency. This innovative device boasts a high capacity, making it a standout choice for genomics research. The X9 Real-Time PCR System represents a significant advancement in the field, enabling researchers to perform real-time polymerase chain reactions with remarkable precision. Its high capacity ensures that a wide range of genetic analyses can be conducted efficiently and effectively.

Stilla Technologies and Promega Corporation have joined forces through a strategic co-marketing agreement, bringing together the expertise of both companies in the realms of sample preparation and cutting-edge genomics technology. This collaboration focuses on harnessing the power of the latest Maxwell systems and digital polymerase chain reaction (PCR) using the six-color Naica system. The partnership between Stilla and Promega Corporation signifies a significant step forward in the field of molecular biology and genomics. By integrating the capabilities of Maxwell systems and digital PCR on the Naica platform, researchers will gain access to a comprehensive and highly advanced solution for their analytical needs.

QIAGEN and GT Molecular have jointly revealed an exciting collaboration aimed at delivering a comprehensive solution for the detection of SARS-CoV-2 in wastewater. This innovative solution is built upon QIAcuity digital PCR technology, signifying a significant advancement in the field of environmental monitoring for viral pathogens. The partnership between QIAGEN and GT Molecular reflects their shared commitment to addressing critical public health challenges, particularly in the context of the ongoing COVID-19 pandemic.

Key Questions Answered in This Report

• 1. How big is the global digital PCR market?
• 2. What is the expected growth rate of the global digital PCR market during 2024-2032?
• 3. What are the key factors driving the global digital PCR market?
• 4. What has been the impact of COVID-19 on the global digital PCR market?
• 5. What is the breakup of the global digital PCR market based on the product type?
• 6. What is the breakup of the global digital PCR market based on the technology?
• 7. What is the breakup of the global digital PCR market based on the application?
• 8. What are the key regions in the global digital PCR market?
• 9. Who are the key players/companies in the global digital PCR market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Digital PCR Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Digital PCR Equipment
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Consumables and Reagents
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Software and Services
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Technology

• 7.1 Droplet Digital PCR
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 BEAMing Digital PCR
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Application

• 8.1 Clinical Diagnostics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Forensics
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Research
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Avance Biosciences Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Bio-Rad Laboratories Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Danaher Corporation
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 JN Medsys
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 OPTOLANE Technologies Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 QIAGEN
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 SAGA Diagnostics AB
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Standard BioTools Inc.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
  • 14.3.9 Stilla Technologies
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Sysmex Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Thermo Fisher Scientific Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis